Is hepatitis C virus infection contagious?

Currently, hepatitis C is a fully curable disease. In the past, treatment for hepatitis C primarily involved long-acting interferon combined with ribavirin, achieving a cure rate of approximately 70%; however, interferon therapy was associated with numerous adverse effects. So, is hepatitis C contagious? Let’s explore this further below.

Is Hepatitis C Contagious?

Hepatitis C virus (HCV) infection is classified as a Category B notifiable infectious disease under China’s national infectious disease reporting system. Hepatitis C is transmitted predominantly via bloodborne routes—including blood transfusions or blood products, needlestick injuries, injections, hemodialysis, sexual contact, mother-to-child transmission, and close personal contact in daily life. Most patients with hepatitis C exhibit only mild clinical symptoms—or even remain asymptomatic—with slow disease progression and a high propensity for chronicity. Without timely and effective treatment, chronic hepatitis C may ultimately progress to cirrhosis or even hepatocellular carcinoma.

At present, hepatitis C is a completely curable disease. Historically, treatment relied on long-acting interferon plus ribavirin, yielding a cure rate of roughly 70% but accompanied by frequent adverse reactions. Today, oral direct-acting antiviral (DAA) agents are the mainstay of therapy, achieving cure rates exceeding 95%, with convenient oral administration and minimal side effects. Numerous DAA medications are now approved and available in China, typically requiring a treatment duration of approximately three months. For patients who have already developed cirrhosis, treatment duration may need to be extended. Even after HCV RNA becomes undetectable, regular follow-up examinations at a medical facility remain essential.

Given that hepatitis C is curable, prompt treatment upon diagnosis is strongly recommended. Prior to initiating therapy, patients should undergo comprehensive baseline evaluations—including HCV genotyping, quantitative HCV RNA testing, routine blood tests, liver function tests, and hepatic ultrasound. Treatment regimens—specifically oral DAAs—are selected based on individual patient characteristics. During treatment, patients should prioritize adequate rest and avoid excessive physical exertion. Lifestyle modifications—including smoking cessation and abstinence from alcohol—are crucial. A light, nutritionally balanced diet is advised. Importantly, individuals with active HCV infection must refrain from donating blood or organs until they achieve sustained virologic clearance confirmed by post-treatment testing.

We hope the above information is helpful to you.